globenewswire.com

Reputation Factor: 3.19 High
Sites Owned: 3
Total Reference Links: 122
Total Citations: 135
Unique Wikipedia Articles Citing: 124

Associated Sites

globenewswire.com

Uncategorized

Links: 1

Citations: 1

ml-eu.globenewswire.com

Uncategorized

Links: 3

Citations: 3

www.globenewswire.com

News

Links: 118

Citations: 131

Top Reference Links

Score	Article	Site	Category	Cited In (Articles)
6.3	Galle Gallants begin new chapter in Lanka Premier League https://www.globenewswire.com/news-release/2026/05/04/3286576/0/en/galle-gallants-announce-new-ownership-under-gallant-sports-and-media-llc-within-urban-gro-flash-sports-media-ipg-operated-lpl-season-6-ecosystem-pubudu-dassanayake-appointed-head-c.html	www.globenewswire.com	News	3
6.3	Chips&Media Completes Development of Next-Gen 'AV2' HW Decoder IP, Accelerating Global Market Leadership https://www.globenewswire.com/news-release/2026/06/10/3309684/0/en/Chips-Media-Completes-Development-of-Next-Gen-AV2-HW-Decoder-IP-Accelerating-Global-Market-Leadership.html	www.globenewswire.com	News	2
6.3	Crinetics Announces FDA Approval of Palsonify (paltusotine) for the Treatment of Adults with Acromegaly https://www.globenewswire.com/news-release/2025/09/25/3156767/0/en/Crinetics-Announces-FDA-Approval-of-PALSONIFY-paltusotine-for-the-Treatment-of-Adults-with-Acromegaly.html	www.globenewswire.com	News	2
6.3	U.S. FDA grants accelerated approval to Boehringer's Hernexeos as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC https://www.globenewswire.com/news-release/2025/08/08/3130334/0/en/U-S-FDA-grants-accelerated-approval-to-Boehringer-s-HERNEXEOS-as-first-orally-administered-targeted-therapy-for-previously-treated-patients-with-HER2-mutant-advanced-NSCLC.html	www.globenewswire.com	News	2
6.3	PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01 https://www.globenewswire.com/news-release/2026/04/27/3281580/0/en/PharmAla-Executes-Binding-Letter-of-Intent-for-Formation-of-Special-Purpose-Vehicle-to-Develop-Patented-Novel-MDXX-Molecule-APA-01.html	www.globenewswire.com	News	2
6.3	Citi(R) Presents A Very Special Performance from Coldplay at the Beacon Theatre https://www.globenewswire.com/en/news-release/2014/04/24/1002696/0/en/Citi-R-Presents-a-Very-Special-Performance-From-Coldplay-at-the-Beacon-Theatre.html	www.globenewswire.com	News	2
3.1	SCO Film and Television Week Kicks Off -- In Qingdao, Connecting the World through Cinema https://www.globenewswire.com/news-release/2025/08/25/3138186/0/en/SCO-Film-and-Television-Week-Kicks-Off-In-Qingdao-Connecting-the-World-through-Cinema.html	www.globenewswire.com	News	1
3.1	Unstoppable Domains and Hub Culture announce .hub ICANN gTLD intent https://www.globenewswire.com/news-release/2026/01/05/3212830/0/en/Unstoppable-Domains-and-Hub-Culture-today-announced-their-intent-to-submit-hub-for-ICANN-s-upcoming-generic-top-level-domain-gtld-application-round.html	www.globenewswire.com	News	1
3.1	WildWorks Names Jazwares as the Master Toy Partner for Animal Jam Brand https://www.globenewswire.com/news-release/2015/10/08/1248583/0/en/WildWorks-Names-Jazwares-as-the-Master-Toy-Partner-for-Animal-Jam-Brand.html	www.globenewswire.com	News	1
3.1	Mount Sinai Researchers in Semifinals of $101 Million XPRIZE Healthspan, a Competition Seeking Innovative Approaches to Aging Well https://www.globenewswire.com/news-release/2025/05/12/3079354/0/en/Mount-Sinai-Researchers-in-Semifinals-of-101-Million-XPRIZE-Healthspan-a-Competition-Seeking-Innovative-Approaches-to-Aging-Well.html	www.globenewswire.com	News	1

Citation Trends Over Time